Cosentyx 150 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26F8N6N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,451
Award facts
- Contract value 100% obligated
- $19,451.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,451.05 to AmerisourceBergen Drug Corp for the supply of Cosentyx 150 mg/ml syringes. This competitively awarded, non-set-aside contract was established on a firm fixed-price basis with an ultimate completion date of January 22, 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The contract represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger indefinite delivery contract with the DLA Troop Support Medical.
Cencora, Inc. holds a substantial $999.9 billion indefinite delivery vehicle with the DLA Troop Support Medical extending through December 2031, which serves as the primary contracting mechanism for supplying pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order for Cosentyx, a specialty pharmaceutical used in the treatment of inflammatory and autoimmune conditions, exemplifies the type of brand-name medications supplied through this comprehensive arrangement. The contract falls within DLA's medical supply chain operations and reflects the agency's reliance on established prime vendors to fulfill critical pharmaceutical requirements across the Department of Defense healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DR26F8N6N?
SPE2DR26F8N6N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F8N6N worth?
The government has obligated $19,451 on SPE2DR26F8N6N.
Is contract SPE2DR26F8N6N an order under another contract?
Yes. SPE2DR26F8N6N is a delivery order under SPE2DR25D3022, an indefinite delivery contract.
Was contract SPE2DR26F8N6N competed?
The extent of competition for SPE2DR26F8N6N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award